Works matching AU Uitdehaag, B M

Results: 47

Spinal cord magnetic resonance imaging in suspected multiple sclerosis.

Published in:

2000

By:

Lycklama à Nijeholt, G. J.;
Uitdehaag, B. M. J.;
Bergers, E.;
Castelijns, J. A.;
Polman, C. H.;
Barkhof, F.;
Lycklama à Nijeholt, G J;
Uitdehaag, B M

Publication type:

journal article

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands.

Published in:

Journal of Medical Economics, 2018, v. 21, n. 10, p. 968, doi. 10.1080/13696998.2018.1489255

By:

Piena, M. A.;
Heisen, M.;
Wormhoudt, L. W.;
Wingerden, J. van;
Frequin, S. T. F. M.;
Uitdehaag, B. M. J.

Publication type:

Article

The relative risk of infection in people with multiple sclerosis using disease-modifying treatment: a systematic review of observational studies.

Published in:

Neurological Sciences, 2025, v. 46, n. 6, p. 2555, doi. 10.1007/s10072-025-08018-9

By:

Leung, M. W. Y.;
Garde, E. M. W. Van de;
Uitdehaag, B. M. J.;
Klungel, O. H.;
Bazelier, M. T.

Publication type:

Article

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats.

Published in:

Clinical & Experimental Immunology, 1990, v. 81, n. 2, p. 183

By:

voorthuis, J. A. C.;
Uitdehaag, B. M. J.;
de Groot, C. J. A.;
Goede, P. H.;
van der Meide, P. H.;
Dijkstra, C. D.

Publication type:

Article

Systematic review of randomized clinical trials of surgical treatment for carpal tunnel syndrome.

Published in:

British Journal of Surgery, 2001, v. 88, n. 10, p. 1285, doi. 10.1046/j.0007-1323.2001.01858.x

By:

Gerritsen, A. A. M.;
Uitdehaag, B. M. J.;
van Geldere, D.;
Scholten, R. J. P. M.;
de Vet, H. C. W.;
Bouter, L. M.

Publication type:

Article

ECT in the treatment of depressed elderly: lessons from a terminated clinical trial.

Published in:

International Journal of Geriatric Psychiatry, 2007, v. 22, n. 10, p. 1052, doi. 10.1002/gps.1800

By:

Stek, M. L.;
Van Der Wurff, F. B.;
Uitdehaag, B. M. J.;
Beekman, A. T. F.;
Hoogendijk, W. J. G.

Publication type:

Article

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

Published in:

Journal of Neurology, 2023, v. 270, n. 4, p. 2271, doi. 10.1007/s00415-022-11554-5

By:

Vrenken, H.;
Battaglini, M.;
de Vos, M. L.;
Nagtegaal, G. J.;
Teixeira, B. C. A.;
Seitzinger, A.;
Jack, D.;
Sormani, M. P.;
Uitdehaag, B. M. J.;
Versteeg, A.;
Comi, G.;
Kappos, L.;
De Stefano, N.;
Barkhof, F.

Publication type:

Article

Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Published in:

European Journal of Neurology, 2020, v. 27, n. 1, p. 144, doi. 10.1111/ene.14048

By:

Coric, D.;
Ometto, G.;
Montesano, G.;
Keane, P. A.;
Balk, L. J.;
Uitdehaag, B. M. J.;
Petzold, A.;
Crabb, D. P.;
Denniston, A. K.

Publication type:

Article

Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Published in:

European Journal of Neurology, 2019, v. 26, n. 6, p. 893, doi. 10.1111/ene.13904

By:

Popescu, V.;
Vrenken, H.;
Dekker, I.;
Wattjes, M. P.;
Barkhof, F.;
Balk, L. J.;
Uitdehaag, B. M. J.;
Killestein, J.;
Eijlers, A. J. C.;
Geurts, J. J. G.;
Schoonheim, M. M.

Publication type:

Article

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands.

Published in:

2018

By:

Piena, M A;
Heisen, M;
Wormhoudt, L W;
van Wingerden, J;
Frequin, S T F M;
Uitdehaag, B M J;
Wingerden, J van

Publication type:

journal article

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

Published in:

Brain: A Journal of Neurology, 2002, v. 125, n. 7, p. 1462, doi. 10.1093/brain/awf165

By:

Petzold, A.;
Eikelenboom, M. J.;
Gveric, D.;
Keir, G.;
Chapman, M.;
Lazeron, R. H. C.;
Cuzner, M. L.;
Polman, C. H.;
Uitdehaag, B. M. J.;
Thompson, E. J.;
Giovannoni, G.

Publication type:

Article

Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype.

Published in:

2001

By:

Head, Mark W.;
Tissingh, Gerrit;
Uitdehaag, Bernard M. J.;
Barkhof, Frederik;
Bunn, Tristan J. R.;
Ironside, James W.;
Kamphorst, Wouter;
Scheltens, Philip;
Head, M W;
Tissingh, G;
Uitdehaag, B M;
Barkhof, F;
Bunn, T J;
Ironside, J W;
Kamphorst, W;
Scheltens, P

Publication type:

journal article

Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis.

Published in:

2001

By:

Van Veen, Tineke;
Crusius, J. Bart A.;
Schrijver, Hans M.;
Bouma, Gerd;
Killestein, Joep;
Van Winsen, Lisa;
Peña, A. Salvador;
Polman, Chris H.;
Uitdehaag, Bernard M.J.;
van Veen, T;
Crusius, J B;
Schrijver, H M;
Bouma, G;
Killestein, J;
van Winsen, L;
Salvador Peña, A;
Polman, C H;
Uitdehaag, B M

Publication type:

Letter

Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis.

Published in:

2000

By:

De Jong, Brigit A.;
Schrijver, Hans M.;
Huizinga, Tom W. J.;
Bollen, Eduard L. E. M.;
Polman, Chris H.;
Uitdehaag, Bernard M. J.;
Kersbergen, Marja C.;
Sturk, Augueste;
Westendorp, Rudi G. J.;
de Jong, B A;
Schrijver, H M;
Huizinga, T W;
Bollen, E L;
Polman, C H;
Uitdehaag, B M;
Kersbergen, M C;
Sturk, A;
Westendorp, R G

Publication type:

journal article

The therapeutic effect of bromocriptine on acute and chronic experimental allergic encephalomyelitis.

Published in:

Annals of Neurology, 1992, v. 31, n. 4, p. 450, doi. 10.1002/ana.410310420

By:

Dijkstra, C. D.;
van der Voort, E. Rouppe;
De Groot, C. J. A.;
Uitdehaag, B. M. J.;
Polman, C. H.;
Berkenbosch, F.

Publication type:

Article

Disease progression in multiple sclerosis: combining physicians’ and patients’ perspectives?

Published in:

Multiple Sclerosis Journal, 2011, v. 17, n. 2, p. 234, doi. 10.1177/1352458510385505

By:

Kragt, J. J.;
Nielsen, J. M.;
van der Linden, F. A. H.;
Polman, C. H.;
Uitdehaag, B. M. J.

Publication type:

Article

A standardized protocol for quantification of saccadic eye movements: DEMoNS.

Published in:

PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0200695

By:

Nij Bijvank, J. A.;
Petzold, A.;
Balk, L. J.;
Tan, H. S.;
Uitdehaag, B. M. J.;
Theodorou, M.;
van Rijn, L. J.

Publication type:

Article

Effect of K<sup>+</sup> channel blockers on the clinical course and histological features of experimental allergic encephalomyelitis.

Published in:

Acta Neurologica Scandinavica, 1994, v. 90, n. 4, p. 299, doi. 10.1111/j.1600-0404.1994.tb02725.x

By:

Uitdehaag, B. M. J.;
Polman, C. H.;
Groot, C. J. A.;
Dijkstra, C. D.

Publication type:

Article

Failure of sulfasalazine to influence experimental autoimmune encephalomyelitis.

Published in:

Acta Neurologica Scandinavica, 1991, v. 84, n. 2, p. 173, doi. 10.1111/j.1600-0404.1991.tb04931.x

By:

Uitdehaag, B. M. J.;
Polman, C. H.;
Groot, C. J. A. de;
Huitinga, I.;
Dijkstra, C. D.

Publication type:

Article

Observations on the lesion site in the Miller Fisher syndrome: presentation of a case including CT and MRI.

Published in:

Acta Neurologica Scandinavica, 1989, v. 80, n. 2, p. 167, doi. 10.1111/j.1600-0404.1989.tb03861.x

By:

Taphoorn, M. J. B.;
Lanting, P.;
Hazenberg, G. J.;
Uitdehaag, B. J. M.;
Kaiser, M.C.

Publication type:

Article

Long-lasting effects of cyclophosphamide on lymphocytes in peripheral blood and spinal fluid.

Published in:

Acta Neurologica Scandinavica, 1989, v. 79, n. 1, p. 12, doi. 10.1111/j.1600-0404.1989.tb03702.x

By:

Uitdehaag, B. M. J.;
Nillesen, W. M.;
Hommes, O. R.

Publication type:

Article

Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis.

Published in:

European Journal of Neurology, 2017, v. 24, n. 12, p. 1479, doi. 10.1111/ene.13443

By:

Coric, D.;
Balk, L. J.;
Uitdehaag, B. M. J.;
Petzold, A.

Publication type:

Article

High cumulative JC virus seroconversion rate during long-term use of natalizumab.

Published in:

European Journal of Neurology, 2016, v. 23, n. 6, p. 1079, doi. 10.1111/ene.12988

By:

Vennegoor, A.;
Rossum, J. A.;
Leurs, C.;
Wattjes, M. P.;
Rispens, T.;
Murk, J. L. A. N.;
Uitdehaag, B. M. J.;
Killestein, J.

Publication type:

Article

Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.

Published in:

European Journal of Neurology, 2012, v. 19, n. 7, p. 1007, doi. 10.1111/j.1468-1331.2012.03668.x

By:

Lalmohamed, A.;
Bazelier, M. T.;
Van Staa, T. P.;
Uitdehaag, B. M. J.;
Leufkens, H. G. M.;
De Boer, A.;
De Vries, F.

Publication type:

Article

Proxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life.

Published in:

European Journal of Neurology, 2008, v. 15, n. 9, p. 933, doi. 10.1111/j.1468-1331.2008.02224.x

By:

van der Linden, F. A. H.;
D’hooghe, M. B.;
Nagels, G.;
Van Nunen, A.;
Polman, C. H.;
Uitdehaag, B. M. J.

Publication type:

Article

The usefulness of evaluative outcome measures in patients with multiple sclerosis.

Published in:

Brain: A Journal of Neurology, 2006, v. 129, n. 10, p. 2648, doi. 10.1093/brain/awl223

By:

V. de Groot;
H. Beckerman;
B. M. J. Uitdehaag;
H. C. W. de Vet;
G. J. Lankhorst;
C. H. Polman;
L. M. Bouter

Publication type:

Article

Predictive value of EEG in neonates with periventricular leukomalacia.

Published in:

Developmental Medicine & Child Neurology, 2003, v. 45, n. 9, p. 586, doi. 10.1017/S0012162203001087

By:

R J Vermeulen;
L T L Sie;
E J Jonkman;
R L M Strijers;
H N Lafeber;
B M J Uitdehaag;
M S van der Knaap

Publication type:

Article

Performance of the Swanton multiple sclerosis criteria for dissemination in space.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 8, p. 985, doi. 10.1177/1352458510369244

By:

Nielsen, J. M.;
Uitdehaag, B. M. J.;
Korteweg, T.;
Barkhof, F.;
Polman, C. H.

Publication type:

Article

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 7, p. 862, doi. 10.1177/1352458510370464

By:

Bosma, L. V. A. E.;
Kragt, J. J.;
Brieva, L.;
Khaleeli, Z.;
Montalban, X.;
Polman, C. H.;
Thompson, A. J.;
Tintoré, M.;
Uitdehaag, B. M. J.

Publication type:

Article

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 6, p. 660, doi. 10.1177/1352458510364630

By:

Van den Elskamp, I. J.;
Knol, D. L.;
Vrenken, H.;
Karas, G.;
Meijerman, A.;
Filippi, M.;
Kappos, L.;
Fazekas, F.;
Wagner, K.;
Pohl, C.;
Sandbrink, R.;
Polman, C. H.;
Uitdehaag, B. M. J.;
Barkhof, F.

Publication type:

Article

Cerebrospinal fluid ATP metabolites in multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 5, p. 549, doi. 10.1177/1352458510364196

By:

Lazzarino, G.;
Amorini, A. M.;
Eikelenboom, M. J.;
Killestein, J.;
Belli, A.;
Di Pietro, V.;
Tavazzi, B.;
Barkhof, F.;
Polman, C. H.;
Uitdehaag, B. M. J.;
Petzold, A.

Publication type:

Article

The search for responsive clinical endpoints in primary progressive multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 6, p. 715, doi. 10.1177/1352458509102626

By:

Bosma, L. V. A. E.;
Kragt, J. J.;
Brieva, L.;
Khaleeli, Z.;
Montalban, X.;
Polman, C. H.;
Thompson, A. J.;
Tintoré, M.;
Uitdehaag, B. M. J.

Publication type:

Article

Association between MRI parameters and the MS severity scale: a 12 year follow-up study.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 5, p. 632, doi. 10.1177/1352458509102617

By:

Minneboo, A.;
Uitdehaag, B. M. J.;
Jongen, P.;
Vrenken, H.;
Knol, D. L.;
van Walderveen, M. A. A.;
Polman, C. H.;
Castelijns, J. A.;
Barkhof, F.

Publication type:

Article

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 4, p. 465

By:

Korteweg, T.;
Rovaris, M.;
Neacsu, V.;
Filippi, M.;
Comi, G.;
Uitdehaag, B. M.;
Knol, D. L.;
Polman, C. H.;
Barkhof, F.;
Vrenken, H.

Publication type:

Article

The distribution of new enhancing lesion counts in multiple sclerosis: further explorations.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 1, p. 42, doi. 10.1177/1352458508096683

By:

van den Elskamp, I. J.;
Knol, D. L.;
Uitdehaag, B. M. J.;
Barkhof, F.

Publication type:

Article

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 1, p. 9, doi. 10.1177/1352458508095920

By:

Kragt, J. J.;
van Amerongen, B. M.;
Killestein, J.;
Dijkstra, C. D.;
Uitdehaag, B. M. J.;
Polman, C. H.;
Lips, P.

Publication type:

Article

No evidence that polymorphisms of the vanishing white matter disease genes are risk factors in multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2008, v. 14, n. 8, p. 1123, doi. 10.1177/1352458508093618

By:

Pronk, I. C.;
Scheper, G. C.;
van Andel, R. I.;
van Berkel, C. G. M.;
Polman, C. H.;
Uitdehaag, B. M. J.;
van der Knaap, M. S.

Publication type:

Article

Long-term follow-up of suspected though unconfirmed MS.

Published in:

Multiple Sclerosis (13524585), 2008, v. 14, n. 7, p. 985, doi. 10.1177/1352458508090922

By:

Nielsen, J. M.;
Uitdehaag, B. M. J.;
Polman, C. H.

Publication type:

Article

Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results.

Published in:

Multiple Sclerosis (13524585), 2007, v. 13, n. 6, p. 717, doi. 10.1177/1352458506074684

By:

Nielsen, J. M.;
Moraal, B.;
Polman, C. H.;
Poppe, P.;
de Vos, M.;
Freedman, M. S.;
Kappos, L.;
Barkhof, F.;
Bauer, L.;
Pohl, C.;
Sandbrink, R.;
Hartung, H.-P.;
Uitdehaag, B. M. J.

Publication type:

Article

How similar are commonly combined criteria for EDSS progression in multiple sclerosis?

Published in:

Multiple Sclerosis (13524585), 2006, v. 12, n. 6, p. 782, doi. 10.1177/1352458506070931

By:

Kragt, J. J.;
Nielsen, J. M.;
van der Linden, F. A. H.;
Uitdehaag, B. M. J;
Polman, C. H.

Publication type:

Article

Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics.

Published in:

Multiple Sclerosis (13524585), 2006, v. 12, n. 5, p. 565, doi. 10.1177/1352458506070759

By:

Zwemmer, J. N. P.;
Berkhof, J.;
Castelijns, J. A.;
Barkhof, F.;
Polman, C. H.;
Uitdehaag, B. M. J.

Publication type:

Article

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2006, v. 12, n. 5, p. 594, doi. 10.1177/1352458506070768

By:

Kragt, J. J.;
van der Linden, F. A. H.;
Nielsen, J. M.;
Uitdehaag, B. M. J.;
Polman, C. H.

Publication type:

Article

The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers.

Published in:

Multiple Sclerosis (13524585), 2006, v. 12, n. 3, p. 325, doi. 10.1191/135248505ms1277oa

By:

Petzold, A.;
Eikelenboom, M. J.;
Keir, G.;
Polman, C. H.;
Uitdehaag, B. M. J.;
Thompson, E. J.;
Giovannoni, G.

Publication type:

Article

The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.

Published in:

Multiple Sclerosis (13524585), 2004, v. 10, n. 1, p. 55, doi. 10.1191/1352458504ms972oa

By:

Hoogervorst, E. L. J.;
Kalkers, N. F.;
Cutter, G. R.;
Uitdehaag, B. M. J.;
Polman, C. H.

Publication type:

Article

A randomized, double-blind, placebo-controlled pilot study of IV immune globulins in combination with IV methylprednisolone in the treatment of relapses in patients with MS.

Published in:

Multiple Sclerosis (13524585), 2004, v. 10, n. 1, p. 89, doi. 10.1191/1352458504ms978sr

By:

Visser, L. H.;
Beekman, R.;
Tijssen, C. C.;
Uitdehaag, B. M. J.;
Lee, M. L.;
Movig, K. L. L.;
Lenderink, A. W.

Publication type:

Article

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.

Published in:

Genes & Immunity, 2012, v. 13, n. 5, p. 443, doi. 10.1038/gene.2012.18

By:

Vosslamber, S;
van der Voort, L F;
van den Elskamp, I J;
Heijmans, R;
Aubin, C;
Uitdehaag, B M J;
Crusius, J B A;
van der Pouw Kraan, T C T M;
Comabella, M;
Montalban, X;
Hafler, D A;
De Jager, P L;
Killestein, J;
Polman, C H;
Verweij, C L

Publication type:

Article

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.

Published in:

Genes & Immunity, 2011, v. 12, n. 6, p. 466, doi. 10.1038/gene.2011.18

By:

Vosslamber, S;
van der Voort, L F;
van den Elskamp, I J;
Heijmans, R;
Aubin, C;
Uitdehaag, B M J;
Crusius, J B A;
van der PouwKraan, T C T M;
Comabella, M;
Montalban, X;
Hafler, D A;
De Jager, P L;
Killestein, J;
Polman, C H;
Verweij, C L

Publication type:

Article